Financhill
Buy
63

IMNM Quote, Financials, Valuation and Earnings

Last price:
$21.70
Seasonality move :
64.59%
Day range:
$21.33 - $22.16
52-week range:
$5.15 - $25.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
177.80x
P/B ratio:
7.54x
Volume:
1M
Avg. volume:
2.4M
1-year change:
95.59%
Market cap:
$2B
Revenue:
$9M
EPS (TTM):
-$2.96

Earnings Data

Next earnings date for IMNM
Mar 19
2026
Most recent earnings per share
-$0.65
Missed by $0.11
(Nov 6/2025)
Consensus Estimate
-$0.54
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

IMNM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/19/2026 Q4 $850K -- -- -$0.57 --
11/06/2025 Q3 $727.3K -- -$0.65 -$0.54 -$0.11
08/06/2025 Q2 $1M $4M -$0.50 -$0.50 -$0.00
05/15/2025 Q1 $457.1K $2.9M -$0.52 -$0.57 $0.05
03/19/2025 Q4 $3.2M $2.7M -$1.28 -$0.61 -$0.67
11/13/2024 Q3 $2.2M $2.9M -$0.78 -$0.58 -$0.20
08/12/2024 Q2 $1.9M $2.4M -$0.60 -$0.40 -$0.20
05/14/2024 Q1 $2.8M $1M -$2.51 -$0.45 -$2.06
03/28/2024 Q4 $2.1M $3.8M -$4.22 -$0.34 -$3.88
11/09/2023 Q3 -- $3.6M -$0.36 -- --
08/09/2023 Q2 -- $4.3M -$0.46 -- --
05/05/2023 Q1 -- $2.4M -$0.35 -- --
03/16/2023 Q4 -- -- -$0.69 -- --
11/14/2022 Q3 -- -- -$0.70 -- --
08/05/2022 Q2 -- -- -$0.74 -- --
05/12/2022 Q1 -- -- -$0.96 -- --
03/28/2022 Q4 -- -- -$0.65 -- --
11/15/2021 Q3 -- -- -$0.65 -- --
08/16/2021 Q2 -- -- -$0.46 -- --
05/12/2021 Q1 -- -- -$0.37 -- --
03/25/2021 Q4 -- -- -$0.38 -- --
11/16/2020 Q3 -- -- -$0.79 -- --
06/30/2020 Q2 -- -- -$0.26 -- --
03/31/2020 Q1 -- -- -$2.44 -- --
12/31/2019 Q4 -- -- -$0.51 -- --
09/30/2019 Q3 -- -- -$0.26 -- --

Immunome, Inc. Earnings Questions

  • How Much did Immunome, Inc. Generate in Revenue Last Quarter?

    Immunome, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Immunome, Inc. Beat Earnings Last Quarter?

    Immunome, Inc. announced earnings per share of -$0.65 which represents a miss of analyst forecast a -$0.54 per share.

  • Is Immunome, Inc. Profitable?

    Immunome, Inc. reported -$733K that represents -$0.01 per share over the last quarter.

  • What is the Analyst Consensus for Immunome, Inc. EPS Next Year?

    Immunome, Inc.'s earnings are forecast to decrease from -$5.00 per share to -$2.20 per share next year representing a decrease of -55.44%.

  • When is Immunome, Inc.'s Earnings Date?

    Immunome, Inc.'s next earnings date is March 19, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
72
GLTO alert for Dec 27

Galecto, Inc. [GLTO] is up 16.92% over the past day.

Sell
20
SMX alert for Dec 27

SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.

Sell
11
CDNAF alert for Dec 27

Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock